Predicting the degree of difficulty of the trans-radial approach in cerebral angiography
- PMID: 32792364
- DOI: 10.1136/neurintsurg-2020-016448
Predicting the degree of difficulty of the trans-radial approach in cerebral angiography
Abstract
Background: To evaluate anatomical and clinical factors that make trans-radial cerebral angiography more difficult.
Methods: A total of 52 trans-radial diagnostic angiograms were evaluated in a tertiary care stroke center from December 2019 until March 2020. We analyzed a number of anatomical variables to evaluate for correlation to outcome measures of angiography difficulty.
Results: The presence of a proximal radial loop had a higher conversion to femoral access (p<0.03). The presence of a large diameter aortic arch (p<0.01), double subclavian innominate curve (p<0.01), left proximal common carotid artery (CCA) loop (p<0.001), acute subclavian vertebral angle (p<0.01), and absence of bovine aortic arch anatomy (p=0.03) were associated with more difficult trans-radial cerebral angiography and increased fluoroscopy time-per-vessel.
Conclusion: The presence of a proximal radial loop, large diameter aortic arch, double subclavian innominate curve, proximal left CCA loop, acute subclavian vertebral angle, and absence of bovine aortic arch anatomy were associated with more difficult trans-radial cerebral angiography. We also introduce a novel grading scale for diagnostic trans-radial angiography.
Keywords: CT Angiography; artery; catheter; guidewire.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: DH serves as a consultant for Covidien/Medtronic and Microvention; and is a shareholder of Cerebrotech, Marblehead Medical, and Silver Bullett. LE serves as a consultant for Balt, Cerenovus, Medtronic, MicroVention, Penumbra, and Stryker. CN has received research support from Microvention. PJ is a consultant for Medtronic and MicroVention. ECP is a consultant for Cerenovus, Medtronic Neurovascular, Penumbra, and Stryker Neurovascular; and is a shareholder of RIST Neurovascular. ASA is a consultant for Johnson and Johnson, Medtronic, Microvention, Penumbra, Scientia, Siemens, and Stryker; receives research support from Balt, Cerenovus, Medtronic, Microvention, Penumbra, Siemens, and Stryker; and is a shareholder in Bendit, Cerebrotech, Endostream, Magneto, Marblehead, Neurogami, Serenity, Synchron, Triad Medical, and Vascular Simulations.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical